Danyelle Townsend

Danyelle Townsend is a Professor at the Medical University of South Carolina (MUSC) in the College of Pharmacy's Department of Drug Discovery and Biomedical Sciences. Her research focuses on redox signaling pathways, mitochondrial dysfunction, and drug development for cancer and chronic diseases. Key areas include oxidative stress mechanisms, protein S-glutathionylation, and targeted drug delivery systems.

Her work integrates molecular pharmacology with translational medicine, emphasizing therapeutic strategies for conditions like intervertebral disc degeneration, multiple myeloma, and melanoma. Notable contributions include studies on CYP3A4 metabolism in pediatric patients and development of pH-sensitive drug delivery systems.

Research highlights include the role of microsomal glutathione transferase 1 (MGST1) in cancer progression and the application of synthetic mitochondrial RNAs to restore bioenergetics. She has published extensively on redox regulation in cell survival pathways and novel anti-cancer agents derived from natural compounds like lapachol.

Dr. Townsend's studies often employ animal models and in vitro systems to evaluate drug efficacy, with a focus on mechanisms linking environmental exposures (e.g., cigarette smoke) to disease progression. Her interdisciplinary approach bridges basic science and clinical applications, targeting both drug discovery and precision medicine strategies.